APOE and cardiovascular disorder: Since its identification in 1973 (Shore and Shore, 1973), ApoE has become one of the most widely studied gene variants, not only for cardiovascular disorders but also in relation to several other medical conditions such as neurodegenerative and autoimmune diseases (Mahley, 1988; Mahley et al., 2009; Verghese et al., 2011).